Inmar Intelligence Hosts 8th Medication Disposal Drive-Thru Event on April 27th
Safely dispose of unused or expired medications at Bolton Elementary School in Winston-Salem.
Understanding DSCSA: Insights for All Dispensers
The article discusses how the DSCSA impacts medication dispensers, emphasizing compliance to protect patient safety and maintain supply chain integrity. It covers pharmaceutical crime, counterfeit drug risks, key DSCSA measures like product serialization, and stresses technology's role in ensuring authenticity. Compliance with regulations is crucial for a secure healthcare environment.
DIR reform in 2024: One step forward, two steps back
The article delves into the advancements and obstacles facing Direct and Indirect Remuneration (DIR) reform in 2024 within the pharmacy sector. It outlines the move from retroactive to upfront DIR fees, the financial pressures on pharmacies, and initiatives to broaden the scope of pharmacy services. Despite certain improvements like clawback elimination, the transition has introduced cash flow difficulties and decreased transparency. The article underscores the significance of comprehending and managing these reforms to bolster pharmacy viability and promote value-based care endeavors.Manufacturer CMOs Reevaluate Retail Media Network Investments
Inmar Intelligence Research Reveals Future Outlook of the State of Retail Media Networks
Successful Returns Management Starts With An Effective Returns Policy
Establishing a clear and consistent returns policy is an absolute requirement for any drug- or device-maker committed to successfully mitigating the financial liability attached to product flowing back through the supply chain.US Department of Health and Human Services Selects Inmar Intelligence for a 5-year Contract to Deliver Pharmaceutical Supply Chain Solutions
Inmar Intelligence, a leading provider of data-driven healthcare technology solutions, today announced it has secured a contract with the US Department of Health and Human Services (HHS) to provide pharmaceutical supply chain solutions across the country.
The Push for Healthcare Price Transparency: Will Pharmacies See a Benefit?
By Jason Murry, Senior Director, Healthcare Sales: Recent passage of the Lower Costs, More Transparency (LCMT) Act in a bipartisan vote by the U.S. House of Representatives is being heralded by the bill’s sponsors as “landmark legislation,” but is it really? The bill -- which is a long way from becoming law -- is focused on the very politically popular issue of lowering prescription drug prices for consumers. But where is the benefit for pharmacies?
What does the future hold for retail media?
Leah Logan: Expect a shift from retail media standardization to transparency. As brands continue to invest more in retail media, they’re looking for a consistent way to talk about and measure performance across the multiple retail media networks — to determine where to invest their budgets. While both brands and retailers see standardization at some level as a necessary step in the evolution of retail media, more complex metrics will be needed to provide rationale for how one RMN is differentiated from another.